2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Vaccines
Cancer vaccines represent a groundbreaking frontier in cancer research, aiming to harness the body's immune system to target and destroy cancer cells. Unlike traditional vaccines that prevent infectious diseases, cancer vaccines are designed to either prevent cancer from developing or treat existing cancer by stimulating the immune response against specific cancerous cells or proteins.
There are different types of cancer vaccines, including preventive vaccines, therapeutic vaccines, and personalized vaccines tailored to an individual's unique cancer profile. Some vaccines target viruses known to cause certain cancers, such as the human papillomavirus (HPV) vaccine for cervical cancer. Others focus on stimulating the immune system to recognize and attack cancer cells bearing specific antigens. While still in the experimental stage for many cancers, cancer vaccines hold great promise for offering new avenues in cancer prevention and treatment.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China